Kappa opioid receptor labeled with Tb (HTRF transiently expressing cells)
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
κ-opioid receptor - Wikipedia
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
The Kappa Opioid Receptor | SpringerLink
Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect
Kappa Receptors – Opioid Peptides
New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects
Building a Safer Opioid: MSK Research Seeks to Develop New Ways to Relieve Pain | Memorial Sloan Kettering Cancer Center
Neurophysiological process - Kappa-type opioid receptor in transmission of nerve impulses Pathway Map - PrimePCR | Life Science | Bio-Rad
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Frontiers | Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain | Journal of Neuroscience
Will peripherally restricted kappa‐opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? - Albert‐Vartanian - 2016 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
Kappa Opioid Receptor Structure Revealed, A Potential Milestone in Medication Development – Maine Suboxone Treatment
Frontiers | Crosstalk Between Kappa Opioid and Dopamine Systems in Compulsive Behaviors
Frontiers | Does the kappa opioid receptor system contribute to pain aversion?
The Role of Opioids and Their Receptors in Urological Malignancy: A Review | Journal of Urology
Z0710N Human Kappa Opioid Receptor (OPRK1) | Montana Molecular
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain | Journal of Neuroscience
Molecules | Free Full-Text | A Structure-Activity Relationship Comparison of Imidazodiazepines Binding at Kappa, Mu, and Delta Opioid Receptors and the GABAA Receptor
